SZN-043

N/A

Report date: 2026/04/27 20:02:09

Base Information

Drug NameSZN-043

Drug Alias NameSZN-043SWEETS-1

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionWnt signalling pathway stimulantsAnti-RNF43Anti-ZNRF3 +[4]

TargetsE3 ubiquitin-protein ligase RNF43E3 ubiquitin-protein ligase ZNRF3Asialoglycoprotein receptor 1

Therapy Area/IndicationsLiver CirrhosisHepatitis, Alcoholic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNew Zealand

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesSurrozen Inc

China Registration ClassN/A

Develop Information

Active CompaniesSurrozen Inc

Inactive CompaniesN/A

Active IndicationsLiver CirrhosisHepatitis, Alcoholic

Inactive IndicationsN/A

Other Information

ATC CodeN/A